Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Pierre Tiberghien and Karine Lacombe.
Pierre Tiberghien
Connection Strength
0.982
Karine Lacombe
  1. Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019. Clin Infect Dis. 2021 10 05; 73(7):e1762-e1765.
    View in: PubMed
    Score: 0.243
  2. A look-back at convalescent plasma to treat COVID-19. Transfus Apher Sci. 2021 02; 60(1):103063.
    View in: PubMed
    Score: 0.231
  3. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood. 2020 11 12; 136(20):2290-2295.
    View in: PubMed
    Score: 0.228
  4. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how? Vox Sang. 2020 Aug; 115(6):488-494.
    View in: PubMed
    Score: 0.220
  5. Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies. Ann Oncol. 2021 11; 32(11):1445-1447.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.